伏立康唑
医学
氟康唑
肝移植
两性霉素B
曲菌病
痰
内科学
移植
胃肠病学
隐球菌病
外科
抗真菌
病理
皮肤病科
免疫学
肺结核
作者
Xianjie Shi,Shao-cheng Lü,Lei He,Fang Lu,Yurong Liang,Ying Luo,Wenbin Ji,Zhiming Zhao
出处
期刊:PubMed
日期:2011-04-01
卷期号:124 (7): 1015-7
被引量:7
摘要
Liver transplantation is the most effective treatment for end-stage liver diseases; however, infections after transplantation can seriously affect the patient's health. The aim of this research was to investigate the diagnosis and treatment of fungal infection following liver transplantation.Clinical data for 232 liver transplant patients at risk of fungal infection were examined for the presence of fungus in the blood, fluid, sputum, urine and stools of patients and by chest or abdominal CT scans. Patients diagnosed with a fungal infection were treated with Fluconazole or, if this was not effective, Voriconazole or Amphotericin B. Immunosuppressive therapy was also reviewed.Thirty-seven of 232 (15.9%) patients were diagnosed with a fungal infection, which occurred 4 to 34 days post-transplantation. Candida infections were diagnosed in 23 cases (62.2%) and Aspergillus infections in 12 cases (32.4%). Twenty-one cases were effectively treated with Fluconazole, 11 cases with Voriconazole, and two cases with Amphotericin B; however, three cases were not effectively treated with any of the antifungal agents. Overall, treatment was effective in 91.9% of patients.Fungal infection has a significant influence on survival rate after liver transplantation. Imaging studies, and pathogenic and biopsy examinations can diagnose fungal infections, which can be effectively treated with antifungal agents such as Fluconazole, Voriconazole or Amphotericin B.
科研通智能强力驱动
Strongly Powered by AbleSci AI